Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and… Apr 13, 2022
Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of… Jan 26, 2022
Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of… Nov 4, 2021
